Immunisation is the cornerstone of polio eradication. Two types of vaccine are available: an inactivated poliovirus vaccine (IPV) and a live attenuated OPV.
The EHFG is the leading health policy event in the EU and takes place annually. It provides a major platform for decision-makers in various fields of public health and health care.
Ebola viruses and Marburg virus are classified as biosafety level 4 (BSL-4) pathogens and require special containment and barrier protection measures, in particular for people taking care of infected patients or bodies.
The overall objective is to support EU Member States in updating their polio preparedness planning. The specific aims of the case study were to: critically review implemented actions and identify gaps in order to propose approaches for strengthening the national polio plans; identify health system elements that are important in polio preparedness planning; and provide examples of collaborative efforts between these sectors in planning measures for outbreak response to polio as a cross-border health threat.